Search

Anna Pagonakis

Examiner (ID: 15443, Phone: (571)270-3505 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
6221, 1628, OPET, 4173, 1614, 1609
Total Applications
1249
Issued Applications
445
Pending Applications
84
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6102601 [patent_doc_number] => 20110166094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/940457 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13453 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166094.pdf [firstpage_image] =>[orig_patent_app_number] => 12940457 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/940457
Agonists of A2A adenosine receptors for treating recurrent tumor growth Nov 4, 2010 Issued
Array ( [id] => 8393173 [patent_doc_number] => 20120231015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'FRAGILE X MENTAL RETARDATION PROTEIN (FMRP), COMPOSITIONS, AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 13/505913 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21315 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505913 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/505913
FRAGILE X MENTAL RETARDATION PROTEIN (FMRP), COMPOSITIONS, AND METHODS RELATED THERETO Nov 3, 2010 Abandoned
Array ( [id] => 6071382 [patent_doc_number] => 20110046233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'GOSSYPOL DERIVATIVES, PRODUCTION METHOD THEREOF AND USES OF SAME' [patent_app_type] => utility [patent_app_number] => 12/939326 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3589 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046233.pdf [firstpage_image] =>[orig_patent_app_number] => 12939326 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/939326
GOSSYPOL DERIVATIVES, PRODUCTION METHOD THEREOF AND USES OF SAME Nov 3, 2010 Abandoned
Array ( [id] => 8696913 [patent_doc_number] => 20130058922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE' [patent_app_type] => utility [patent_app_number] => 13/508159 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4819 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508159 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/508159
PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE Nov 2, 2010 Abandoned
Array ( [id] => 9355447 [patent_doc_number] => 08673980 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer' [patent_app_type] => utility [patent_app_number] => 13/504990 [patent_app_country] => US [patent_app_date] => 2010-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10000 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504990 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/504990
Closthioamides, compositions, and methods for treating bacterial or fungal infections or cancer Nov 1, 2010 Issued
Array ( [id] => 8721240 [patent_doc_number] => 20130072458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'Methods of Treating Viral Associated Diseases' [patent_app_type] => utility [patent_app_number] => 13/504785 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 45139 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504785 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/504785
Methods of Treating Viral Associated Diseases Oct 28, 2010 Abandoned
Array ( [id] => 5986771 [patent_doc_number] => 20110098258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Transdermal Pharmaceutical Compositions Comprising Active Agents' [patent_app_type] => utility [patent_app_number] => 12/912310 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20450 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098258.pdf [firstpage_image] =>[orig_patent_app_number] => 12912310 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/912310
Transdermal pharmaceutical compositions comprising active agents Oct 25, 2010 Issued
Array ( [id] => 5986699 [patent_doc_number] => 20110098232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis' [patent_app_type] => utility [patent_app_number] => 12/911723 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6961 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098232.pdf [firstpage_image] =>[orig_patent_app_number] => 12911723 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/911723
Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis Oct 24, 2010 Abandoned
Array ( [id] => 8442380 [patent_doc_number] => 20120258997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'NEW APPLICATION OF 2-PYRROLIDONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/503556 [patent_app_country] => US [patent_app_date] => 2010-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2607 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503556 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/503556
Use of piracetam for treating diabetic nephropathy Oct 22, 2010 Issued
Array ( [id] => 8430988 [patent_doc_number] => 20120252863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'TRIPTANS FOR THE TREATMENT OF PSORIASIS' [patent_app_type] => utility [patent_app_number] => 13/503418 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4797 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503418 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/503418
Triptans for the treatment of psoriasis Oct 21, 2010 Issued
Array ( [id] => 5954306 [patent_doc_number] => 20110034494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'REVERSIBLE INHIBITION OF SPERM RECEPTOR SYNTHESIS FOR CONTRACEPTION' [patent_app_type] => utility [patent_app_number] => 12/910098 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4871 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034494.pdf [firstpage_image] =>[orig_patent_app_number] => 12910098 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/910098
REVERSIBLE INHIBITION OF SPERM RECEPTOR SYNTHESIS FOR CONTRACEPTION Oct 21, 2010 Abandoned
Array ( [id] => 8442354 [patent_doc_number] => 20120258970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Compositions and Methods for the Treatment of Drug-Induced Hand-Foot Syndrome' [patent_app_type] => utility [patent_app_number] => 13/502209 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5944 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502209 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/502209
Compositions and methods for the treatment of drug-induced hand-foot syndrome Oct 14, 2010 Issued
Array ( [id] => 8503238 [patent_doc_number] => 20120302645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'USE OF HYDROXYTYROSOL FOR IMPROVING MUSCLE DIFFERENTIATION' [patent_app_type] => utility [patent_app_number] => 13/500740 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7287 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500740 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/500740
USE OF HYDROXYTYROSOL FOR IMPROVING MUSCLE DIFFERENTIATION Oct 7, 2010 Abandoned
Array ( [id] => 8442330 [patent_doc_number] => 20120258944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'ANTIOXIDANTS FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 13/499872 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11161 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499872 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/499872
ANTIOXIDANTS FOR USE IN THERAPY Oct 3, 2010 Abandoned
Array ( [id] => 6079834 [patent_doc_number] => 20110142756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer' [patent_app_type] => utility [patent_app_number] => 12/897366 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 83 [patent_no_of_words] => 23591 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142756.pdf [firstpage_image] =>[orig_patent_app_number] => 12897366 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/897366
Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer Oct 3, 2010 Abandoned
Array ( [id] => 8465715 [patent_doc_number] => 20120270884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/497726 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16831 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497726 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/497726
Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors Sep 29, 2010 Abandoned
Array ( [id] => 6150028 [patent_doc_number] => 20110021623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'SYSTEM AND METHODS OF MELANOMA PREVENTION' [patent_app_type] => utility [patent_app_number] => 12/895227 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1804 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021623.pdf [firstpage_image] =>[orig_patent_app_number] => 12895227 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/895227
SYSTEM AND METHODS OF MELANOMA PREVENTION Sep 29, 2010 Abandoned
Array ( [id] => 5944981 [patent_doc_number] => 20110105601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK' [patent_app_type] => utility [patent_app_number] => 12/892431 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7320 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105601.pdf [firstpage_image] =>[orig_patent_app_number] => 12892431 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/892431
COMPOSITIONS FOR USE IN TREATING OR PREVENTING METABOLIC STRESS-INDUCED LUNG INJURY AND METHODS FOR INCREASING PHYSICAL CAPACITY OF MAMMALIAN LIVESTOCK Sep 27, 2010 Abandoned
Array ( [id] => 5937633 [patent_doc_number] => 20110212978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Combination of ZD6474 and Pemetrexed' [patent_app_type] => utility [patent_app_number] => 12/892478 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7661 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212978.pdf [firstpage_image] =>[orig_patent_app_number] => 12892478 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/892478
Combination of ZD6474 and Pemetrexed Sep 27, 2010 Abandoned
Array ( [id] => 6201962 [patent_doc_number] => 20110064748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'PHARMACEUTICAL COMBINATION AND METHOD FOR TREATING TUMOR' [patent_app_type] => utility [patent_app_number] => 12/882794 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7307 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064748.pdf [firstpage_image] =>[orig_patent_app_number] => 12882794 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/882794
Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor Sep 14, 2010 Issued
Menu